Divisadero Street Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-214,860
Closed -$1.93M 166
2025
Q3
$1.93M Sell
214,860
-4,058
-2% -$35.6K 0.08% 110
2025
Q2
$2.85M Sell
218,918
-666,514
-75% -$10M 0.18% 71
2025
Q1
$22.4M Buy
885,432
+72,897
+9% +$2.17M 2.25% 15
2024
Q4
$27.9M Buy
812,535
+38,895
+5% +$1.75M 3.26% 11
2024
Q3
$38.2M Buy
773,640
+683,640
+760% +$35M 4.64% 8
2024
Q2
$5.42M Hold
90,000
0.82% 33
2024
Q1
$4.64M Sell
90,000
-70,000
-44% -$3.44M 1.09% 26
2023
Q4
$6.45M Sell
160,000
-520,000
-76% -$15.3M 1.46% 23
2023
Q3
$19M Buy
680,000
+480,000
+240% +$14.3M 5.98% 6
2023
Q2
$5.76M Buy
+200,000
New +$4.45M 1.66% 20

Other funds holding RXST

Divisadero Street Capital Management's RXST Position: Q4 2025 in Review

Divisadero Street Capital Management sold out of RxSight (RXST) in Q4 2025, closing a stake of 214,860 shares — an estimated $1.93M sold.

Divisadero Street Capital Management first reported a position in RXST in Q2 2023 and held it in 10 quarters. The position peaked at $38.2M in Q3 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

  • Divisadero Street Capital Management reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
  • Divisadero Street Capital Management sold 214,860 RxSight shares in Q4 2025, an estimated $1.93M.
  • Divisadero Street Capital Management first reported a position in RxSight in Q2 2023 and held it in 10 quarters.
  • Divisadero Street Capital Management's RxSight position peaked at $38.2M in Q3 2024.
  • 163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Divisadero Street Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.